[Clinical evaluation of vecuronium bromide in collaboration with nine departments of anesthesiology].
Suzuki
H
H
Tai
K
K
Katsumata
N
N
Itagaki
T
T
Kimura
T
T
Goto
Y
Y
Furukawa
K
K
Irimada
T
T
Hashimoto
Y
Y
Amaha
K
K
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000762:Anesthesia Recovery Period; D000769:Anesthesia, Inhalation; D001794:Blood Pressure / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009466:Neuromuscular Blocking Agents; D010197:Pancuronium / Q000031:analogs & derivatives* / Q000494:pharmacology; D014673:Vecuronium Bromide
D009466:Neuromuscular Blocking Agents; D014673:Vecuronium Bromide; D010197:Pancuronium